The 12-3-12 cationic gemini surfactant as a novel gastrointestinal bioadhesive material for improving the oral bioavailability of coenzyme Q10 naked nanocrystals

References

• Zhu Y-P, Masuyama A, Okahara M. Preparation and surface active properties of amphipathic compounds with two sulfate groups and two lipophilic alkyl chains. J Am Oil Chem Soc 1990;67:459–63.
   Web of Science ®Google Scholar
• Camesano TA, Nagarajan R. Micelle formation and CMC of gemini surfactants: a thermodynamic model. Colloids Surf A Physicochem Eng Asp 2000;167:165–77.
   Web of Science ®Google Scholar
• Menger FM, Littau CA. Gemini surfactants: a new class of self-assembling molecules. J Am Chem Soc 1993;115:10083–90.
   Web of Science ®Google Scholar
• Rosen M, Tracy D. Gemini surfactants. J Surfactants Deterg 1998;1:547–54.
   Google Scholar
• Chen L, Xie H. Properties of carbon nanotube nanofluids stabilized by cationic gemini surfactant. Thermochimica Acta 2010;506:62–6.
   Web of Science ®Google Scholar
• Chen Q, Han L, Gao C, Che S. Synthesis of monodispersed mesoporous silica spheres (MMSSs) with controlled particle size using gemini surfactant. Microporous Mesoporous Mater 2010;128:203–12.
   Web of Science ®Google Scholar
• Haque S, Md S, Alam MI, et al. Nanostructure-based drug delivery systems for brain targeting. Drug Dev Ind Pharm 2012;38:387–411.
   PubMed Web of Science ®Google Scholar
• Branco MA, Pinheiro L, Faustino C. Amino acid-based cationic gemini surfactant–protein interactions. Colloids Surf A Physicochem Eng Asp 2015;480:105–12.
   Web of Science ®Google Scholar
• Cosimati R, Milardi G, Bombelli C, et al. Interactions of DMPC and DMPC/gemini liposomes with the cell membrane investigated by electrorotation. Biochim Biophys Acta 2013;1828:352–6.
   PubMed Web of Science ®Google Scholar
• Pietralik Z, Kumita JR, Dobson CM, Kozak M. The influence of novel gemini surfactants containing cycloalkyl side-chains on the structural phases of DNA in solution. Colloids Surf B Biointerfaces 2015;131:83–92.
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Iwamoto S, Mukai M, Kikuchi J-I. Photo- and thermo-responsive assembly of liposomal membranes triggered by a gemini peptide lipid as a molecular switch. J Photochem Photobiol A Chem 2006;183:309–14.
   Web of Science ®Google Scholar
• Ding M, He X, Wang Z, et al. Cellular uptake of polyurethane nanocarriers mediated by gemini quaternary ammonium. Biomaterials 2011;32:9515–24.
   PubMed Web of Science ®Google Scholar
• Zaghloul AA, Gurley B, Khan M, et al. Bioavailability assessment of oral coenzyme Q10 formulations in dogs. Drug Dev Ind Pharm 2002;28:1195–200.
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413–20.
   PubMed Web of Science ®Google Scholar
• Amar-Yuli I, Aserin A, Garti N, et al. Coenzyme Q10: functional benefits, dietary uptake and delivery mechanisms. In: McClements J, Decker EA, eds. Designing functional foods: measuring and controlling food structure breakdown and nutrient absorption. Cambridge: Woodhead Publishing Limited; 2009:676–700.
   Google Scholar
• Mitchell P. Possible molecular mechanisms of the protonmotive function of cytochrome systems. J Theor Biol 1976;62:327–67.
   PubMed Web of Science ®Google Scholar
• Chen S, Liu W, Wan J, et al. Preparation of coenzyme Q10 nanostructured lipid carriers for epidermal targeting with high-pressure microfluidics technique. Drug Dev Ind Pharm 2013;39:20–8.
   PubMed Web of Science ®Google Scholar
• Lönnrot K, MetsÄ-KetelÄ T, Molnár G, et al. The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity. Free Radic Biol Med 1996;21:211–17.
   PubMed Web of Science ®Google Scholar
• Lee B-J, Huang Y-C, Chen S-J, Lin P-T. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease. Nutrition 2012;28:250–5.
   PubMed Web of Science ®Google Scholar
• Mortensen SA, Rosenfeldt F, Kumar A, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail 2014;2:641–9.
   PubMed Web of Science ®Google Scholar
• Kumar A, Kaur H, Devi P, Mohan V. Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome. Pharmacol Ther 2009;124:259–68.
   PubMed Web of Science ®Google Scholar
• Lim SCLR, Goh SK, et al. The effect of coenzyme Q10 on microcirculatory endothelial function of subjects with type 2 diabetes mellitus. Atherosclerosis 2008;9:966–192.
   Web of Science ®Google Scholar
• Borekova MHJ, Koprda V, et al. Nourishing and health benefits of coenzyme Q10 – a review. Czech J Food Sci 2008;26:229–41.
   Web of Science ®Google Scholar
• Prosek M, Butinar J, Lukanc B, et al. Bioavailability of water-soluble CoQ10 in beagle dogs. J Pharm Biomed Anal 2008;47:918–22.
   PubMed Web of Science ®Google Scholar
• Nazzal S, Guven N, Reddy IK, Khan MA. Preparation and characterization of coenzyme Q10-Eudragit solid dispersion. Drug Dev Ind Pharm 2002;28:49–57.
   PubMed Web of Science ®Google Scholar
• Onoue S, Terasawa N, Nakamura T, et al. Biopharmaceutical characterization of nanocrystalline solid dispersion of coenzyme Q10 prepared with cold wet-milling system. Eur J Pharm Sci 2014;53:118–25.
   PubMed Web of Science ®Google Scholar
• Swarnakar NK, Jain AK, Singh RP, et al. Oral bioavailability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles. Biomaterials 2011;32:6860–74.
   PubMed Web of Science ®Google Scholar
• Lee W-C, Tsai T-H. Preparation and characterization of liposomal coenzyme Q10 for in vivo topical application. Int J Pharm 2010;395:78–83.
   PubMed Web of Science ®Google Scholar
• Koynova R, Tihova M. Nanosized self-emulsifying lipid vesicles of diacylglycerol-PEG lipid conjugates: biophysical characterization and inclusion of lipophilic dietary supplements. Biochim Biophys Acta 2010;1798:646–53.
   PubMed Web of Science ®Google Scholar
• Belhaj N, Dupuis F, Arab-Tehrany E, et al. Formulation, characterization and pharmacokinetic studies of coenzyme Q10 PUFA’s nanoemulsions. Eur J Pharm Sci 2012;47:305–12.
   PubMed Web of Science ®Google Scholar
• Shegokar R, Müller RH. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int J Pharm 2010;399:129–39.
   PubMed Web of Science ®Google Scholar
• Sun J, Wang F, Sui Y, et al. Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q(1)(0) as naked nanocrystals. Int J Nanomed 2012;7:5733–44.
   PubMed Web of Science ®Google Scholar
• Shi Y, Zou M, An Y, et al. A potent preparation method combining neutralization with microfluidization for rebamipide nanosuspensions and its in vivo evaluation. Drug Dev Ind Pharm 2013;39:996–1004.
   PubMed Web of Science ®Google Scholar
• Ponchel G, Montisci M-J, Dembri A, et al. Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract. Eur J Pharm Biopharm 1997;44:25–31.
   Web of Science ®Google Scholar
• Ponchel G, Irache JM. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev 1998;34:191–219.
   PubMed Web of Science ®Google Scholar
• Teng C, Ho N. Mechanistic studies in the simultaneous flow and adsorption of polymer-coated latex particles on intestinal mucus I: methods and physical model development. J Control Release 1987;6:133–49.
   Google Scholar
• Palamakula A, Soliman M, Khan MMA. Regional permeability of coenzyme Q10 in isolated rat gastrointestinal tracts. Pharmazie 2005;60:212–14.
   PubMed Web of Science ®Google Scholar
• Durrer C, Irache JM, Puisieux F, et al. Mucoadhesion of latexes. I. Analytical methods and kinetic studies. Pharm Res 1994;11:674–9.
   PubMed Web of Science ®Google Scholar
• Mortensen S, Vadhanavikit S, Muratsu K, Folkers K. Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure. Int J Tissue React 1990;12:155.
   PubMedGoogle Scholar
• Choi HK, Pokharel YR, Lim SC, et al. Inhibition of liver fibrosis by solubilized coenzyme Q10: role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression. Toxicol Appl Pharmacol 2009;240:377–84.
   PubMed Web of Science ®Google Scholar
• Kagan VE, Quinn PJ. Coenzyme Q: molecular mechanisms in health and disease. Boca Raton (FL): CRC Press; 2000:212.
   Google Scholar
• Rahmat D, Müller C, Shahnaz G, et al. HEC-cysteamine particles: influence of particle size, zeta potential, morphology and sulfhydryl groups on permeation enhancing properties. Drug Dev Ind Pharm 2013;39:1338–45.
   PubMed Web of Science ®Google Scholar